- Romeo, MM
- Ko, B
- Kim, J
- Brady, R
- Heatley, HC
- He, J
- Harrod, CK
- Barnett, B
- Ratner, L
- Lairmore, MD
- Martinez, E
- Lüscher, B
- Robson, CN
- Henriksson, M
- Harrod, R
- et al.
© 2014 Elsevier Inc. The human T-cell leukemia retrovirus type-1 (HTLV-1) p30IIprotein is a multifunctional latency-maintenance factor that negatively regulates viral gene expression and deregulates host signaling pathways involved in aberrant T-cell growth and proliferation. We have previously demonstrated that p30IIinteracts with the c-MYC oncoprotein and enhances c-MYC-dependent transcriptional and oncogenic functions. However, the molecular and biochemical events that mediate the cooperation between p30IIand c-MYC remain to be completely understood. Herein we demonstrate that p30IIinduces lysine-acetylation of the c-MYC oncoprotein. Acetylation-defective c-MYC Lys→Arg substitution mutants are impaired for oncogenic transformation with p30IIin c-myc-/-HO15.19 fibroblasts. Using dual-chromatin-immunoprecipitations (dual-ChIPs), we further demonstrate that p30IIis present in c-MYC-containing nucleoprotein complexes in HTLV-1-transformed HuT-102 T-lymphocytes. Moreover, p30IIinhibits apoptosis in proliferating cells expressing c-MYC under conditions of genotoxic stress. These findings suggest that c-MYC-acetylation is required for the cooperation between p30II/c-MYC which could promote proviral replication and contribute to HTLV-1-induced carcinogenesis.